Research location
Algiers
Algeria
Advertisement
Research activity in Algiers
AlgeriaCureCurrent currently publishes aggregate city-level research activity for this location: 44 trials and 86 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Algiers
44 linked trials · page 1 of 1OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management ProgrammeNCT07779343 · 2026-01-22 · 1 site observation
RECRUITING
Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic DiseaseNCT07542496 · 2026-01-15 · 2 site observations
RECRUITING
To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of TreatmentNCT06500494 · 2024-09-10 · 1 site observation
ACTIVE_NOT_RECRUITING
SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes TrialNCT04972721 · 2023-09-01 · 1 site observation
COMPLETED
Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID.NCT05601180 · 2022-10-27 · 2 site observations
COMPLETED
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisNCT05134441 · 2021-11-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With SchizophreniaNCT05563818 · 2021-11-09 · 1 site observation
COMPLETED
A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in AlgeriaNCT03862690 · 2020-05-28 · 1 site observation
WITHDRAWN
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 DiabetesNCT04109547 · 2019-10-01 · 2 site observations
COMPLETED
A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 DiabetesNCT04017832 · 2019-07-29 · 2 site observations
COMPLETED
A Heart Disease Study of Semaglutide in Patients With Type 2 DiabetesNCT03914326 · 2019-06-17 · 1 site observation
COMPLETED
An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 DiabetesNCT03811288 · 2018-12-10 · 1 site observation
COMPLETED
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityNCT03574597 · 2018-10-24 · 4 site observations
COMPLETED
Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to FulvestrantNCT03447132 · 2017-12-20 · 1 site observation
COMPLETED
Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical PracticeNCT03607812 · 2017-06-28 · 1 site observation
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise OnlyNCT02906930 · 2016-09-20 · 4 site observations
COMPLETED
National Lung Cancer Registry in Men and Women Based on Diagnosis in AlgeriaNCT02725892 · 2016-07-19 · 1 site observation
COMPLETED
Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)NCT02921035 · 2016-06-30 · 1 site observation
COMPLETED
Tracking Biologics Along the Silk RoadNCT03006198 · 2016-02-04 · 1 site observation
COMPLETED
Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After RamadanNCT02648217 · 2016-01-04 · 1 site observation
COMPLETED
Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinNCT02582242 · 2015-10-19 · 2 site observations
COMPLETED
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World SettingsNCT02322762 · 2014-12-30 · 1 site observation
COMPLETED
Global Non-interventional Heart Failure Disease RegistryNCT02595814 · 2014-07-23 · 3 site observations
TERMINATED
A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast CancerNCT01964391 · 2014-02-21 · 2 site observations
COMPLETED
Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 DiabetesNCT01917656 · 2014-01-09 · 1 site observation
COMPLETED
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate CancerNCT02066961 · 2013-12-31 · 2 site observations
COMPLETED
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular EventsNCT01959529 · 2013-10-29 · 1 site observation
COMPLETED
A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice DailyNCT01814137 · 2013-03-01 · 1 site observation
COMPLETED
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime InsulinNCT01713530 · 2013-02-21 · 1 site observation
COMPLETED
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin GlargineNCT01680341 · 2012-08-31 · 1 site observation
COMPLETED
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast CancerNCT01572038 · 2012-06-01 · 1 site observation
COMPLETED
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerNCT01566721 · 2012-05-17 · 1 site observation
COMPLETED
Diabetes Attitudes Wishes and NeedsNCT01507116 · 2012-03-01 · 1 site observation
COMPLETED
A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 DiabetesNCT01513590 · 2012-01-16 · 1 site observation
COMPLETED
Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk PatientsNCT01853839 · 2011-10-01 · 26 site observations
COMPLETED
Africa and Middle East Cardiovascular Epidemiological StudyNCT01243138 · 2011-07-01 · 1 site observation
COMPLETED
Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering DrugsNCT01203111 · 2010-12-01 · 1 site observation
COMPLETED
baSal BoluS Therapy in patIenTs With TypE 1 Diabetes MellitusNCT01204593 · 2010-11-01 · 3 site observations
COMPLETED
Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsNCT01068652 · 2010-03-01 · 1 site observation
COMPLETED
Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic MedicationNCT00869908 · 2008-11-01 · 1 site observation
COMPLETED
H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast CancerNCT01991340 · 2008-11-01 · 1 site observation
COMPLETED
ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide CombinationNCT00708344 · 2008-06-01 · 1 site observation
COMPLETED
Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 DiabetesNCT00700830 · 2008-01-01 · 1 site observation
COMPLETED
APROVE : Irbesartan in HypertensionNCT00283036 · 2005-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.